img

Global Orphan Drugs Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Orphan Drugs Market Insights, Forecast to 2034

Orphan drugs are medicines that are used to treat diseases that cannot be produced profitably without the assistance of the government because there are so few patients. Conditions that are treated are known as rare diseases.
Market Analysis and InsightsGlobal Orphan Drugs Market
Global Orphan Drugs market is expected to reach to US$ million in 2023, with a positive growth of %, compared with US$ million in 2024 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Orphan Drugs industry is evaluated to reach US$ million in 2034. The CAGR will be % during 2023 to 2034.
Globally, Orphan Drugs key companies include Amber Specialty Pharmacy, Alexion Pharmaceuticals (Astra AB), Johnson & Johnson, Novartis, Celgene (Bristol-Myers Squibb), AbbVie, GSK, Roche and Sanofi, etc. Amber Specialty Pharmacy, Alexion Pharmaceuticals (Astra AB), Johnson & Johnson are top 3 players and held % share in total in 2024.
When considering the consumption regions, % revenue of Orphan Drugs were sold to North America, Europe and Asia Pacific in 2024. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2034 and the share will be % in 2034. Moreover, China, plays a key role in the whole Orphan Drugs market and estimated to attract more attentions from industry insiders and investors.
Orphan Drugs can be divided into Biopharmaceutical and Other, etc. Biopharmaceutical is the mainstream product in the market, accounting for % revenue share globally in 2024 and the proportion will be % in 2034.
Orphan Drugs is widely used in various fields, such as Child and Aldult, etc. Child provides greatest supports to the Orphan Drugs industry development. In 2024, global % revenue of Orphan Drugs went into Child filed and the proportion will reach to % in 2034.
Report Covers
This report presents an overview of global Orphan Drugs market from 2018 to 2034, aiming to help readers to get a comprehensive understanding of global Orphan Drugs market with multiple angles. Items like regional revenue from 2018 to 2034 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2034 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Amber Specialty Pharmacy
Alexion Pharmaceuticals (Astra AB)
Johnson & Johnson
Novartis
Celgene (Bristol-Myers Squibb)
AbbVie
GSK
Roche
Sanofi
Pfizer
Vertex
Merck & Co.
Segment by Type
Biopharmaceutical
Other

Segment by Application


Child
Aldult
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2034
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2034 globally
Chapter 5Product revenue analysis by application from 2018 to 2034 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2034 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2034
Chapter 7Product revenue analysis by type and application from 2018 to 2034 in Europe. Product revenue analysis of each country in Europe from 2018 to 2034
Chapter 8Product revenue analysis by type and application from 2018 to 2034 in China. Product revenue analysis of China from 2018 to 2034
Chapter 9Product revenue analysis by type and application from 2018 to 2034 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2034
Chapter 10Product revenue analysis by type and application from 2018 to 2034 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2034.
Chapter 11Companies’ outline, covering company’s basic information, major business, Orphan Drugs introduction, etc. Orphan Drugs Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12Mr Accuracy reports’s Conclusions of Orphan Drugs
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Orphan Drugs Market Size Growth Rate by Type, 2018 VS 2024 VS 2034
1.2.2 Biopharmaceutical
1.2.3 Other
1.3 Market by Application
1.3.1 Global Orphan Drugs Market Size Growth Rate by Application, 2018 VS 2024 VS 2034
1.3.2 Child
1.3.3 Aldult
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Orphan Drugs Market Perspective (2018-2034)
2.2 Global Orphan Drugs Growth Trends by Region
2.2.1 Orphan Drugs Market Size by Region: 2018 VS 2024 VS 2034
2.2.2 Orphan Drugs Historic Market Size by Region (2018-2023)
2.2.3 Orphan Drugs Forecasted Market Size by Region (2024-2034)
2.3 Orphan Drugs Market Dynamics
2.3.1 Orphan Drugs Industry Trends
2.3.2 Orphan Drugs Market Drivers
2.3.3 Orphan Drugs Market Challenges
2.3.4 Orphan Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Orphan Drugs by Players
3.1.1 Global Orphan Drugs Revenue by Players (2018-2023)
3.1.2 Global Orphan Drugs Revenue Market Share by Players (2018-2023)
3.2 Global Orphan Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Orphan Drugs, Ranking by Revenue, 2021 VS 2024 VS 2023
3.4 Global Orphan Drugs Market Concentration Ratio
3.4.1 Global Orphan Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Orphan Drugs Revenue in 2024
3.5 Global Key Players of Orphan Drugs Head office and Area Served
3.6 Global Key Players of Orphan Drugs, Product and Application
3.7 Global Key Players of Orphan Drugs, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Orphan Drugs Breakdown Data by Type
4.1 Global Orphan Drugs Historic Market Size by Type (2018-2023)
4.2 Global Orphan Drugs Forecasted Market Size by Type (2024-2034)
5 Orphan Drugs Breakdown Data by Application
5.1 Global Orphan Drugs Historic Market Size by Application (2018-2023)
5.2 Global Orphan Drugs Forecasted Market Size by Application (2024-2034)
6 North America
6.1 North America Orphan Drugs Market Size (2018-2034)
6.2 North America Orphan Drugs Market Size by Type
6.2.1 North America Orphan Drugs Market Size by Type (2018-2023)
6.2.2 North America Orphan Drugs Market Size by Type (2024-2034)
6.2.3 North America Orphan Drugs Market Share by Type (2018-2034)
6.3 North America Orphan Drugs Market Size by Application
6.3.1 North America Orphan Drugs Market Size by Application (2018-2023)
6.3.2 North America Orphan Drugs Market Size by Application (2024-2034)
6.3.3 North America Orphan Drugs Market Share by Application (2018-2034)
6.4 North America Orphan Drugs Market Size by Country
6.4.1 North America Orphan Drugs Market Size by Country: 2018 VS 2024 VS 2034
6.4.2 North America Orphan Drugs Market Size by Country (2018-2023)
6.4.3 North America Orphan Drugs Market Size by Country (2024-2034)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Orphan Drugs Market Size (2018-2034)
7.2 Europe Orphan Drugs Market Size by Type
7.2.1 Europe Orphan Drugs Market Size by Type (2018-2023)
7.2.2 Europe Orphan Drugs Market Size by Type (2024-2034)
7.2.3 Europe Orphan Drugs Market Share by Type (2018-2034)
7.3 Europe Orphan Drugs Market Size by Application
7.3.1 Europe Orphan Drugs Market Size by Application (2018-2023)
7.3.2 Europe Orphan Drugs Market Size by Application (2024-2034)
7.3.3 Europe Orphan Drugs Market Share by Application (2018-2034)
7.4 Europe Orphan Drugs Market Size by Country
7.4.1 Europe Orphan Drugs Market Size by Country: 2018 VS 2024 VS 2034
7.4.2 Europe Orphan Drugs Market Size by Country (2018-2023)
7.4.3 Europe Orphan Drugs Market Size by Country (2024-2034)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Orphan Drugs Market Size (2018-2034)
8.2 China Orphan Drugs Market Size by Type
8.2.1 China Orphan Drugs Market Size by Type (2018-2023)
8.2.2 China Orphan Drugs Market Size by Type (2024-2034)
8.2.3 China Orphan Drugs Market Share by Type (2018-2034)
8.3 China Orphan Drugs Market Size by Application
8.3.1 China Orphan Drugs Market Size by Application (2018-2023)
8.3.2 China Orphan Drugs Market Size by Application (2024-2034)
8.3.3 China Orphan Drugs Market Share by Application (2018-2034)
9 Asia (excluding China)
9.1 Asia Orphan Drugs Market Size (2018-2034)
9.2 Asia Orphan Drugs Market Size by Type
9.2.1 Asia Orphan Drugs Market Size by Type (2018-2023)
9.2.2 Asia Orphan Drugs Market Size by Type (2024-2034)
9.2.3 Asia Orphan Drugs Market Share by Type (2018-2034)
9.3 Asia Orphan Drugs Market Size by Application
9.3.1 Asia Orphan Drugs Market Size by Application (2018-2023)
9.3.2 Asia Orphan Drugs Market Size by Application (2024-2034)
9.3.3 Asia Orphan Drugs Market Share by Application (2018-2034)
9.4 Asia Orphan Drugs Market Size by Region
9.4.1 Asia Orphan Drugs Market Size by Region: 2018 VS 2024 VS 2034
9.4.2 Asia Orphan Drugs Market Size by Region (2018-2023)
9.4.3 Asia Orphan Drugs Market Size by Region (2024-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Orphan Drugs Market Size (2018-2034)
10.2 Middle East, Africa, and Latin America Orphan Drugs Market Size by Type
10.2.1 Middle East, Africa, and Latin America Orphan Drugs Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Orphan Drugs Market Size by Type (2024-2034)
10.2.3 Middle East, Africa, and Latin America Orphan Drugs Market Share by Type (2018-2034)
10.3 Middle East, Africa, and Latin America Orphan Drugs Market Size by Application
10.3.1 Middle East, Africa, and Latin America Orphan Drugs Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Orphan Drugs Market Size by Application (2024-2034)
10.3.3 Middle East, Africa, and Latin America Orphan Drugs Market Share by Application (2018-2034)
10.4 Middle East, Africa, and Latin America Orphan Drugs Market Size by Country
10.4.1 Middle East, Africa, and Latin America Orphan Drugs Market Size by Country: 2018 VS 2024 VS 2034
10.4.2 Middle East, Africa, and Latin America Orphan Drugs Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Orphan Drugs Market Size by Country (2024-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Amber Specialty Pharmacy
11.1.1 Amber Specialty Pharmacy Company Details
11.1.2 Amber Specialty Pharmacy Business Overview
11.1.3 Amber Specialty Pharmacy Orphan Drugs Introduction
11.1.4 Amber Specialty Pharmacy Revenue in Orphan Drugs Business (2018-2023)
11.1.5 Amber Specialty Pharmacy Recent Developments
11.2 Alexion Pharmaceuticals (Astra AB)
11.2.1 Alexion Pharmaceuticals (Astra AB) Company Details
11.2.2 Alexion Pharmaceuticals (Astra AB) Business Overview
11.2.3 Alexion Pharmaceuticals (Astra AB) Orphan Drugs Introduction
11.2.4 Alexion Pharmaceuticals (Astra AB) Revenue in Orphan Drugs Business (2018-2023)
11.2.5 Alexion Pharmaceuticals (Astra AB) Recent Developments
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Details
11.3.2 Johnson & Johnson Business Overview
11.3.3 Johnson & Johnson Orphan Drugs Introduction
11.3.4 Johnson & Johnson Revenue in Orphan Drugs Business (2018-2023)
11.3.5 Johnson & Johnson Recent Developments
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Novartis Business Overview
11.4.3 Novartis Orphan Drugs Introduction
11.4.4 Novartis Revenue in Orphan Drugs Business (2018-2023)
11.4.5 Novartis Recent Developments
11.5 Celgene (Bristol-Myers Squibb)
11.5.1 Celgene (Bristol-Myers Squibb) Company Details
11.5.2 Celgene (Bristol-Myers Squibb) Business Overview
11.5.3 Celgene (Bristol-Myers Squibb) Orphan Drugs Introduction
11.5.4 Celgene (Bristol-Myers Squibb) Revenue in Orphan Drugs Business (2018-2023)
11.5.5 Celgene (Bristol-Myers Squibb) Recent Developments
11.6 AbbVie
11.6.1 AbbVie Company Details
11.6.2 AbbVie Business Overview
11.6.3 AbbVie Orphan Drugs Introduction
11.6.4 AbbVie Revenue in Orphan Drugs Business (2018-2023)
11.6.5 AbbVie Recent Developments
11.7 GSK
11.7.1 GSK Company Details
11.7.2 GSK Business Overview
11.7.3 GSK Orphan Drugs Introduction
11.7.4 GSK Revenue in Orphan Drugs Business (2018-2023)
11.7.5 GSK Recent Developments
11.8 Roche
11.8.1 Roche Company Details
11.8.2 Roche Business Overview
11.8.3 Roche Orphan Drugs Introduction
11.8.4 Roche Revenue in Orphan Drugs Business (2018-2023)
11.8.5 Roche Recent Developments
11.9 Sanofi
11.9.1 Sanofi Company Details
11.9.2 Sanofi Business Overview
11.9.3 Sanofi Orphan Drugs Introduction
11.9.4 Sanofi Revenue in Orphan Drugs Business (2018-2023)
11.9.5 Sanofi Recent Developments
11.10 Pfizer
11.10.1 Pfizer Company Details
11.10.2 Pfizer Business Overview
11.10.3 Pfizer Orphan Drugs Introduction
11.10.4 Pfizer Revenue in Orphan Drugs Business (2018-2023)
11.10.5 Pfizer Recent Developments
11.11 Vertex
11.11.1 Vertex Company Details
11.11.2 Vertex Business Overview
11.11.3 Vertex Orphan Drugs Introduction
11.11.4 Vertex Revenue in Orphan Drugs Business (2018-2023)
11.11.5 Vertex Recent Developments
11.12 Merck & Co.
11.12.1 Merck & Co. Company Details
11.12.2 Merck & Co. Business Overview
11.12.3 Merck & Co. Orphan Drugs Introduction
11.12.4 Merck & Co. Revenue in Orphan Drugs Business (2018-2023)
11.12.5 Merck & Co. Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Orphan Drugs Market Size Growth Rate by Type (US$ Million), 2018 VS 2024 VS 2034
Table 2. Key Players of Biopharmaceutical
Table 3. Key Players of Other
Table 4. Global Orphan Drugs Market Size Growth Rate by Application (US$ Million), 2018 VS 2024 VS 2034
Table 5. Global Orphan Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2024 VS 2034
Table 6. Global Orphan Drugs Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Orphan Drugs Market Share by Region (2018-2023)
Table 8. Global Orphan Drugs Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 9. Global Orphan Drugs Market Share by Region (2024-2034)
Table 10. Orphan Drugs Market Trends
Table 11. Orphan Drugs Market Drivers
Table 12. Orphan Drugs Market Challenges
Table 13. Orphan Drugs Market Restraints
Table 14. Global Orphan Drugs Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Orphan Drugs Revenue Share by Players (2018-2023)
Table 16. Global Top Orphan Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Orphan Drugs as of 2024)
Table 17. Global Orphan Drugs Industry Ranking 2021 VS 2024 VS 2023
Table 18. Global 5 Largest Players Market Share by Orphan Drugs Revenue (CR5 and HHI) & (2018-2023)
Table 19. Global Key Players of Orphan Drugs, Headquarters and Area Served
Table 20. Global Key Players of Orphan Drugs, Product and Application
Table 21. Global Key Players of Orphan Drugs, Product and Application
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Orphan Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Orphan Drugs Revenue Market Share by Type (2018-2023)
Table 25. Global Orphan Drugs Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 26. Global Orphan Drugs Revenue Market Share by Type (2024-2034)
Table 27. Global Orphan Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Orphan Drugs Revenue Share by Application (2018-2023)
Table 29. Global Orphan Drugs Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 30. Global Orphan Drugs Revenue Share by Application (2024-2034)
Table 31. North America Orphan Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 32. North America Orphan Drugs Market Size by Type (2024-2034) & (US$ Million)
Table 33. North America Orphan Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 34. North America Orphan Drugs Market Size by Application (2024-2034) & (US$ Million)
Table 35. North America Orphan Drugs Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 36. North America Orphan Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 37. North America Orphan Drugs Market Size by Country (2024-2034) & (US$ Million)
Table 38. Europe Orphan Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 39. Europe Orphan Drugs Market Size by Type (2024-2034) & (US$ Million)
Table 40. Europe Orphan Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 41. Europe Orphan Drugs Market Size by Application (2024-2034) & (US$ Million)
Table 42. Europe Orphan Drugs Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 43. Europe Orphan Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 44. Europe Orphan Drugs Market Size by Country (2024-2034) & (US$ Million)
Table 45. China Orphan Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 46. China Orphan Drugs Market Size by Type (2024-2034) & (US$ Million)
Table 47. China Orphan Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 48. China Orphan Drugs Market Size by Application (2024-2034) & (US$ Million)
Table 49. Asia Orphan Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 50. Asia Orphan Drugs Market Size by Type (2024-2034) & (US$ Million)
Table 51. Asia Orphan Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 52. Asia Orphan Drugs Market Size by Application (2024-2034) & (US$ Million)
Table 53. Asia Orphan Drugs Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2024 VS 2034
Table 54. Asia Orphan Drugs Market Size by Region (2018-2023) & (US$ Million)
Table 55. Asia Orphan Drugs Market Size by Region (2024-2034) & (US$ Million)
Table 56. Middle East, Africa, and Latin America Orphan Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Orphan Drugs Market Size by Type (2024-2034) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Orphan Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Orphan Drugs Market Size by Application (2024-2034) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Orphan Drugs Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 61. Middle East, Africa, and Latin America Orphan Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Orphan Drugs Market Size by Country (2024-2034) & (US$ Million)
Table 63. Amber Specialty Pharmacy Company Details
Table 64. Amber Specialty Pharmacy Business Overview
Table 65. Amber Specialty Pharmacy Orphan Drugs Product
Table 66. Amber Specialty Pharmacy Revenue in Orphan Drugs Business (2018-2023) & (US$ Million)
Table 67. Amber Specialty Pharmacy Recent Developments
Table 68. Alexion Pharmaceuticals (Astra AB) Company Details
Table 69. Alexion Pharmaceuticals (Astra AB) Business Overview
Table 70. Alexion Pharmaceuticals (Astra AB) Orphan Drugs Product
Table 71. Alexion Pharmaceuticals (Astra AB) Revenue in Orphan Drugs Business (2018-2023) & (US$ Million)
Table 72. Alexion Pharmaceuticals (Astra AB) Recent Developments
Table 73. Johnson & Johnson Company Details
Table 74. Johnson & Johnson Business Overview
Table 75. Johnson & Johnson Orphan Drugs Product
Table 76. Johnson & Johnson Revenue in Orphan Drugs Business (2018-2023) & (US$ Million)
Table 77. Johnson & Johnson Recent Developments
Table 78. Novartis Company Details
Table 79. Novartis Business Overview
Table 80. Novartis Orphan Drugs Product
Table 81. Novartis Revenue in Orphan Drugs Business (2018-2023) & (US$ Million)
Table 82. Novartis Recent Developments
Table 83. Celgene (Bristol-Myers Squibb) Company Details
Table 84. Celgene (Bristol-Myers Squibb) Business Overview
Table 85. Celgene (Bristol-Myers Squibb) Orphan Drugs Product
Table 86. Celgene (Bristol-Myers Squibb) Revenue in Orphan Drugs Business (2018-2023) & (US$ Million)
Table 87. Celgene (Bristol-Myers Squibb) Recent Developments
Table 88. AbbVie Company Details
Table 89. AbbVie Business Overview
Table 90. AbbVie Orphan Drugs Product
Table 91. AbbVie Revenue in Orphan Drugs Business (2018-2023) & (US$ Million)
Table 92. AbbVie Recent Developments
Table 93. GSK Company Details
Table 94. GSK Business Overview
Table 95. GSK Orphan Drugs Product
Table 96. GSK Revenue in Orphan Drugs Business (2018-2023) & (US$ Million)
Table 97. GSK Recent Developments
Table 98. Roche Company Details
Table 99. Roche Business Overview
Table 100. Roche Orphan Drugs Product
Table 101. Roche Revenue in Orphan Drugs Business (2018-2023) & (US$ Million)
Table 102. Roche Recent Developments
Table 103. Sanofi Company Details
Table 104. Sanofi Business Overview
Table 105. Sanofi Orphan Drugs Product
Table 106. Sanofi Revenue in Orphan Drugs Business (2018-2023) & (US$ Million)
Table 107. Sanofi Recent Developments
Table 108. Pfizer Company Details
Table 109. Pfizer Business Overview
Table 110. Pfizer Orphan Drugs Product
Table 111. Pfizer Revenue in Orphan Drugs Business (2018-2023) & (US$ Million)
Table 112. Pfizer Recent Developments
Table 113. Vertex Company Details
Table 114. Vertex Business Overview
Table 115. Vertex Orphan Drugs Product
Table 116. Vertex Revenue in Orphan Drugs Business (2018-2023) & (US$ Million)
Table 117. Vertex Recent Developments
Table 118. Merck & Co. Company Details
Table 119. Merck & Co. Business Overview
Table 120. Merck & Co. Orphan Drugs Product
Table 121. Merck & Co. Revenue in Orphan Drugs Business (2018-2023) & (US$ Million)
Table 122. Merck & Co. Recent Developments
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Orphan Drugs Market Size Growth Rate by Type, 2018 VS 2024 VS 2034 (US$ Million)
Figure 2. Global Orphan Drugs Market Share by Type: 2024 VS 2034
Figure 3. Biopharmaceutical Features
Figure 4. Other Features
Figure 5. Global Orphan Drugs Market Size Growth Rate by Application, 2018 VS 2024 VS 2034 (US$ Million)
Figure 6. Global Orphan Drugs Market Share by Application: 2024 VS 2034
Figure 7. Child Case Studies
Figure 8. Aldult Case Studies
Figure 9. Orphan Drugs Report Years Considered
Figure 10. Global Orphan Drugs Market Size (US$ Million), Year-over-Year: 2018-2034
Figure 11. Global Orphan Drugs Market Size, (US$ Million), 2018 VS 2024 VS 2034
Figure 12. Global Orphan Drugs Market Share by Region: 2024 VS 2034
Figure 13. Global Orphan Drugs Market Share by Players in 2024
Figure 14. Global Top Orphan Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Orphan Drugs as of 2024)
Figure 15. The Top 10 and 5 Players Market Share by Orphan Drugs Revenue in 2024
Figure 16. North America Orphan Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 17. North America Orphan Drugs Market Share by Type (2018-2034)
Figure 18. North America Orphan Drugs Market Share by Application (2018-2034)
Figure 19. North America Orphan Drugs Market Share by Country (2018-2034)
Figure 20. United States Orphan Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 21. Canada Orphan Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 22. Europe Orphan Drugs Market Size YoY (2018-2034) & (US$ Million)
Figure 23. Europe Orphan Drugs Market Share by Type (2018-2034)
Figure 24. Europe Orphan Drugs Market Share by Application (2018-2034)
Figure 25. Europe Orphan Drugs Market Share by Country (2018-2034)
Figure 26. Germany Orphan Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 27. France Orphan Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 28. U.K. Orphan Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 29. Italy Orphan Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 30. Russia Orphan Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 31. Nordic Countries Orphan Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 32. China Orphan Drugs Market Size YoY (2018-2034) & (US$ Million)
Figure 33. China Orphan Drugs Market Share by Type (2018-2034)
Figure 34. China Orphan Drugs Market Share by Application (2018-2034)
Figure 35. Asia Orphan Drugs Market Size YoY (2018-2034) & (US$ Million)
Figure 36. Asia Orphan Drugs Market Share by Type (2018-2034)
Figure 37. Asia Orphan Drugs Market Share by Application (2018-2034)
Figure 38. Asia Orphan Drugs Market Share by Region (2018-2034)
Figure 39. Japan Orphan Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 40. South Korea Orphan Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 41. China Taiwan Orphan Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 42. Southeast Asia Orphan Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 43. India Orphan Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 44. Australia Orphan Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 45. Middle East, Africa, and Latin America Orphan Drugs Market Size YoY (2018-2034) & (US$ Million)
Figure 46. Middle East, Africa, and Latin America Orphan Drugs Market Share by Type (2018-2034)
Figure 47. Middle East, Africa, and Latin America Orphan Drugs Market Share by Application (2018-2034)
Figure 48. Middle East, Africa, and Latin America Orphan Drugs Market Share by Country (2018-2034)
Figure 49. Brazil Orphan Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 50. Mexico Orphan Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 51. Turkey Orphan Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 52. Saudi Arabia Orphan Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 53. Israel Orphan Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 54. GCC Countries Orphan Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 55. Amber Specialty Pharmacy Revenue Growth Rate in Orphan Drugs Business (2018-2023)
Figure 56. Alexion Pharmaceuticals (Astra AB) Revenue Growth Rate in Orphan Drugs Business (2018-2023)
Figure 57. Johnson & Johnson Revenue Growth Rate in Orphan Drugs Business (2018-2023)
Figure 58. Novartis Revenue Growth Rate in Orphan Drugs Business (2018-2023)
Figure 59. Celgene (Bristol-Myers Squibb) Revenue Growth Rate in Orphan Drugs Business (2018-2023)
Figure 60. AbbVie Revenue Growth Rate in Orphan Drugs Business (2018-2023)
Figure 61. GSK Revenue Growth Rate in Orphan Drugs Business (2018-2023)
Figure 62. Roche Revenue Growth Rate in Orphan Drugs Business (2018-2023)
Figure 63. Sanofi Revenue Growth Rate in Orphan Drugs Business (2018-2023)
Figure 64. Pfizer Revenue Growth Rate in Orphan Drugs Business (2018-2023)
Figure 65. Vertex Revenue Growth Rate in Orphan Drugs Business (2018-2023)
Figure 66. Merck & Co. Revenue Growth Rate in Orphan Drugs Business (2018-2023)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries